{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:06:52Z","timestamp":1784758012121,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jinf.2024.106156","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T16:12:27Z","timestamp":1712592747000},"page":"106156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3024-3906","authenticated-orcid":false,"given":"Qingze","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9621-529X","authenticated-orcid":false,"given":"Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0723","authenticated-orcid":false,"given":"Andrew","family":"Brent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Llewelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim E.A.","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen B.","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Eyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jinf.2024.106156_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jinf.2024.106156_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","article-title":"Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis","volume":"13","author":"Wacker","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2024.106156_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","article-title":"Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals","volume":"21","author":"Kadri","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10325","key":"10.1016\/j.jinf.2024.106156_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray Christopher","year":"2022","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jinf.2024.106156_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022133","article-title":"Use of C-reactive protein to tailor antibiotic use: a systematic review and meta-analysis","volume":"8","author":"Petel","year":"2018","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jinf.2024.106156_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cpt.2194","article-title":"Biomarker-guided individualization of antibiotic therapy","volume":"110","author":"Aulin","year":"2021","journal-title":"Clin Pharm Ther"},{"issue":"11","key":"10.1016\/j.jinf.2024.106156_bib7","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1093\/jac\/dkw295","article-title":"Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy","volume":"71","author":"Ramos-Mart\u00edn","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2024.106156_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/FTD.0000000000000507","article-title":"Exploring the use of C-reactive protein to estimate the pharmacodynamics of vancomycin","volume":"40","author":"Rawson","year":"2018","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1186\/s12879-021-06621-7","article-title":"Informing antimicrobial management in the context of COVID-19: understanding the longitudinal dynamics of C-reactive protein and procalcitonin","volume":"21","author":"Ming","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"19","key":"10.1016\/j.jinf.2024.106156_bib10","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.3390\/jcm12196110","article-title":"Kinetics of C-reactive protein and procalcitonin in the early identification of ICU-acquired infections in critically ill COVID-19 patients","volume":"12","author":"Cidade","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jinf.2024.106156_bib11","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1093\/cid\/ciaa876","article-title":"C-reactive protein, procalcitonin, and white blood count to rule out neonatal early-onset sepsis within 36\u2009h: a secondary analysis of the neonatal procalcitonin intervention study","volume":"73","author":"Stocker","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2024.106156_bib12","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s00134-022-06890-z","article-title":"Development and validation of novel sepsis subphenotypes using trajectories of vital signs","volume":"48","author":"Bhavani","year":"2022","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.jinf.2024.106156_bib13","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1086\/430382","article-title":"Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection","volume":"40","author":"P\u00f3voa","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.CCM.0000297886.32564.CF","article-title":"C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia","volume":"36","author":"Lisboa","year":"2008","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.jinf.2024.106156_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2010.06.005","article-title":"C-reactive protein: a tool in the follow-up of nosocomial pneumonia","volume":"61","author":"Moreno","year":"2010","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.jinf.2024.106156_bib16","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc10313","article-title":"C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study","volume":"15","author":"P\u00f3voa","year":"2011","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jinf.2024.106156_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s15010-007-7077-9","article-title":"The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis","volume":"36","author":"Schmit","year":"2008","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2024.106156_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijid.2020.03.063","article-title":"C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection","volume":"95","author":"P\u00f3voa","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"20","key":"10.1016\/j.jinf.2024.106156_bib19","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour Christopher","year":"2019","journal-title":"JAMA"},{"issue":"S450","key":"10.1016\/j.jinf.2024.106156_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.2006.tb02378.x","article-title":"WHO child growth standards based on length\/height, weight and age","volume":"95","year":"2006","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.jinf.2024.106156_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1164\/rccm.201806-1197OC","article-title":"Identifying novel sepsis subphenotypes using temperature trajectories","volume":"200","author":"Bhavani","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jinf.2024.106156_bib22","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/CCM.0000000000004610","article-title":"Temperature trajectory subphenotypes correlate with immune responses in patients with sepsis","volume":"48","author":"Bhavani","year":"2020","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jinf.2024.106156_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/SHK.0000000000001906","article-title":"Temperature trajectory sub-phenotypes and the immuno-inflammatory response in pediatric sepsis","volume":"57","author":"Yehya","year":"2022","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12879-023-08054-w","article-title":"Influence of systolic blood pressure trajectory on in-hospital mortality in patients with sepsis","volume":"23","author":"Zhu","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2024.106156_bib25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s12630-022-02282-5","article-title":"White blood cell count trajectory and mortality in septic shock: a historical cohort study","volume":"69","author":"Rimmer","year":"2022","journal-title":"Can J Anesth Can Anesth"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13054-020-2768-z","article-title":"Defining persistent critical illness based on growth trajectories in patients with sepsis","volume":"24","author":"Zhang","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13054-022-04071-4","article-title":"Sepsis subphenotyping based on organ dysfunction trajectory","volume":"26","author":"Xu","year":"2022","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jointm.2021.11.001","article-title":"Analysis of the correlation between the longitudinal trajectory of SOFA scores and prognosis in patients with sepsis at 72\u2009h after admission based on group trajectory modeling","volume":"2","author":"Yang","year":"2022","journal-title":"J Intensive Med"},{"key":"10.1016\/j.jinf.2024.106156_bib29","unstructured":"Yoon CH, Yuan K, Gu Q, Munby HNP, Walker AS, Zhu T, et al. Using natural language processing on drug indications to predict working sources of infection. Machine Learning for Healthcare; 2023. Available at: https:\/\/www.mlforhc.org. Accessed July 22, 2023."},{"key":"10.1016\/j.jinf.2024.106156_bib30","series-title":"The Sanford Guide to Antimicrobial Therapy 2023","author":"Gilbert David","year":"2023"},{"key":"10.1016\/j.jinf.2024.106156_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v078.i02","article-title":"Estimation of extended mixed models using latent classes and latent processes: the R package lcmm","volume":"78","author":"Proust-Lima","year":"2017","journal-title":"J Stat Softw"},{"issue":"10","key":"10.1016\/j.jinf.2024.106156_bib32","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/sim.4780111005","article-title":"Smoothing reference centile curves: the lms method and penalized likelihood","volume":"11","author":"Cole","year":"1992","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.jinf.2024.106156_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00134-002-1209-6","article-title":"C-reactive protein: a valuable marker of sepsis","volume":"28","author":"P\u00f3voa","year":"2002","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.jinf.2024.106156_bib34","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2110-5820-2-32","article-title":"Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review","volume":"2","author":"P\u00f3voa","year":"2012","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00134-021-06574-0","article-title":"Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study","volume":"48","author":"Peters-Sengers","year":"2022","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-018-2050-9","article-title":"Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia","volume":"22","author":"Thomas-R\u00fcddel","year":"2018","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jinf.2024.106156_bib38","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc8898","article-title":"Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia","volume":"14","author":"Abe","year":"2010","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2334-7-106","article-title":"Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study","volume":"7","author":"Vandijck","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2024.106156_bib40","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1183\/09031936.00003608","article-title":"Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia","volume":"32","author":"Bruns","year":"2008","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jinf.2024.106156_bib41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1469-0691.2010.03284.x","article-title":"Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study","volume":"17","author":"Gradel","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2024.106156_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13054-018-2125-7","article-title":"Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials","volume":"22","author":"Wirz","year":"2018","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.jinf.2024.106156_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2024.106156_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1469-0691.2009.02709.x","article-title":"Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission\u2014a randomized trial","volume":"15","author":"Kristoffersen","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.jinf.2024.106156_bib45","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmi.2018.05.011","article-title":"Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study)","volume":"24","author":"van der Does","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"10.1016\/j.jinf.2024.106156_bib46","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1001\/jama.2020.6348","article-title":"Effect of C-reactive protein\u2013guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated Gram-negative bacteremia: a randomized clinical trial","volume":"323","author":"von Dach","year":"2020","journal-title":"JAMA"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:17:15Z","timestamp":1741616235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0163445324000902"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106156","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106156"}}